Supply of PVMS Drugs for Directorate of Procurement (Navy), Islamabad

The Directorate of Procurement (Navy), Islamabad, invites sealed bids from original manufacturers, authorized distributors, and suppliers registered with income tax and sales tax departments for the supply of PVMS Drugs as per the detailed schedule in the DP-2 form. Items being procured: - Erythromycin Syrup/Suspension 125 MG (4,000 units) - Erythromycin 250 MG Tablets/Capsules (100,000 units) - Erythromycin 500 MG Tablets/Capsules (120,000 units) - Meropenem 500 MG Vial (80,000 units) - Meropenem 1 GM Vial (120,000 units) - Piperacillin & Tazobactam 4.5 GM Vial (10,000 units) The procurement covers medicines with strict adherence to technical specifications, shelf life requirements, and packaging standards. Delivery is scheduled from 1st July 2027 to 30th June 2028 on a supply order basis. The technical offer must be submitted in duplicate and include all required documents such as DGDP registration, DRAP license, tax certificates, and manufacturer authorization. Earnest money must be submitted in a separate sealed envelope as per tender conditions. Evaluation will follow a Single Stage Two Envelope bidding procedure with technical offers evaluated first, followed by commercial offers of technically qualified firms. Bidders must comply with PPRA Rules 2004 and DPP&I-35 (Revised 2024). The tender closing date is **27 October 2026 at 1030 hours**, with bid opening at 1100 hours the same day at the Directorate of Procurement (Navy), Bahria Gate, Naval Residential Complex, Sector E-8, Islamabad. Bidders are advised to carefully follow submission instructions and ensure all documents are complete to avoid rejection. A practical tip: ensure your technical offer clearly marks compliance with each specification and attach all required certificates to avoid disqualification during technical evaluation.